Manchester will host the European Association for Cancer Research from 9-12 July after being seen as the global centre of excellence for research into the life-threatening disease.
Scientists from all around Europe are set to converge on Manchester to share their latest research with the city’s world-leading experts at a special conference at ‘Manchester Central Convention Complex’.
The Congress, which forms part of Manchester City of Science, will see experts share work spanning from basic research to precision medicine – where treatments can be tailored towards individual patients’ differing tumours.
Scientists from Cancer Research UK Manchester Institute and The University of Manchester will be amongst those showcasing their innovative work in the city which was crowned this year’s European city of Science.
European Association for Cancer Research President Professor Richard Marais, who is also Director of Cancer Research UK Manchester Institute, said the convention is an important event for the city.
Professor Marais, who is currently based at the University of Manchester, has also said “Manchester is a city of medical and healthcare pioneers and the day provides an environment where innovation can grow and prosper.
“It is a hub for top global pharmaceutical, medtech and biotech companies – there are 250 life sciences companies in the region, as well as four universities with a strong track record of working with industry.
“This congress features an exciting scientific programme, with world-class speakers covering all of the most ground-breaking research topics from basic research into the biology and understanding of cancer right through to precision medicine.
The conference will open with a speech from Sir Harpal Kumar, Cancer Research UK’s chief executive, who suggests the best way to predict the future is to invent it.